Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleRole of stem cell transplant in chronic myeloid leukemia in contemporary settingsFull text |  PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_15_2024 |
23,159 | 55,521 | 78,680 |
Case ReportGastric cancer or hodgkin lymphoma? Unraveling the diagnostic dilemma of primary gastric classical hodgkin lymphomaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_28_2024 |
20,367 | 56,285 | 76,652 |
Case ReportCase report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancyFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_26_2024 |
14,019 | 62,485 | 76,504 |
Cardio Oncology with ACOSImmune checkpoint inhibitor-induced acute fulminant myocarditis: A case report and review of literatureFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_33_2024 |
20,250 | 55,245 | 75,495 |
Case ReportNUTM1-BRD4 fusion mutation-positive salivary gland myoepithelial carcinoma: A diagnostic conundrumFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_2_2025 |
19,102 | 56,013 | 75,115 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
55,627 | 4,741 | 60,368 |
Review ArticleAntibody-drug conjugate review in breast cancer: A targeted approachFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_30_2024 |
15,469 | 44,601 | 60,070 |
Case ReportBreast carcinoma disguised as systemic sclerosis: A case report of unusual paraneoplastic syndromeFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_4_2024 |
19,425 | 37,856 | 57,281 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_26_2020 |
47,246 | 6,761 | 54,007 |
Review ArticleGenetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosisFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_11_2024 |
14,527 | 36,458 | 50,985 |
Review ArticleEmerging strategies in cancer immunotherapy: Expanding horizons and future perspectivesFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_24_2024 |
21,842 | 21,849 | 43,691 |
Case ReportNivolumab-induced vitiligo in a patient treated for metastatic melanomaFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_10_2025 |
10,244 | 32,689 | 42,933 |
Review ArticleEmerging role of immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinomaFull text | PDF Volume 10 | Issue 3 | September-December 2025DOI: 10.25259/IJMIO_22_2025 |
11,319 | 31,488 | 42,807 |
Case ReportReal life experience of complete remission with modified MEMMAT regimen with LACE induction followed by ASCT as consolidation in Recurrent Medulloblastoma -A case reportFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_31_2024 |
10,165 | 32,007 | 42,172 |
Case SeriesReal-world experience of chronomodulated prescription of cyclin-dependent kinases 4/6 inhibitor palbociclib in reducing hematological toxicity – A case seriesFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_34_2024 |
9,902 | 31,671 | 41,573 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_12_2023 |
29,986 | 4,039 | 34,025 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_15_2023 |
28,686 | 3,846 | 32,532 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_20_2023 |
28,132 | 3,788 | 31,920 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_18_2023 |
25,464 | 4,972 | 30,436 |
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_16_2023 |
26,437 | 3,953 | 30,390 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_17_2023 |
24,242 | 3,053 | 27,295 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_21_2019 |
19,881 | 7,137 | 27,018 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_5_2022 |
16,797 | 8,540 | 25,337 |
Review ArticleRedefining treatment-free remission criteria in chronic myeloid leukemia in IndiaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_10_2024 |
22,952 | 1,896 | 24,848 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_1_2024 |
19,835 | 4,133 | 23,968 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_2_2024 |
19,254 | 4,697 | 23,951 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_3_2024 |
19,610 | 4,321 | 23,931 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_6_2023 |
18,978 | 4,576 | 23,554 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_8_2022 |
16,008 | 7,308 | 23,316 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Volume 6 | Issue 3 | September-December 2021 |
17,983 | 5,180 | 23,163 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_22_2023 |
19,416 | 3,628 | 23,044 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_19_2019 |
15,232 | 7,784 | 23,016 |
Review ArticlePatient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigmaFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_17_2024 |
18,884 | 2,948 | 21,832 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_1_2022 |
14,357 | 6,342 | 20,699 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_29_2022 |
16,355 | 3,842 | 20,197 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_7_2021 |
14,642 | 5,424 | 20,066 |
Review ArticleGenomic profiling of retinoblastoma using aqueous humor liquid biopsy – A rapid reviewFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_25_2024 |
19,367 | 643 | 20,010 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_16_2021 |
15,925 | 3,879 | 19,804 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_26_2021 |
13,067 | 6,680 | 19,747 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_2_2022 |
13,387 | 6,014 | 19,401 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_12_2021 |
14,729 | 4,620 | 19,349 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_27_2022 |
16,885 | 2,432 | 19,317 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_15_2020 |
12,503 | 6,785 | 19,288 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_13_2021 |
15,776 | 3,497 | 19,273 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_2_2019 |
11,861 | 7,187 | 19,048 |
Review ArticleCombination of PARPi and anti-PD-L1 therapies in ovarian cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_28_2022 |
16,194 | 2,785 | 18,979 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Volume 7 | Issue 3 | September-December 2022DOI: 10.25259/IJMIO_14_2022 |
12,705 | 6,181 | 18,886 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_28_2020 |
12,900 | 5,802 | 18,702 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_11_2023 |
15,512 | 3,178 | 18,690 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_5_2023 |
14,822 | 3,725 | 18,547 |